Ann: Update on US FDA De Novo Classification Request, page-199

I’ll say this in a non sarcastic way compared to the other guy.

You are trying to reassure yourself of your investment.

No chance Tony has rejected Sanofi, if there was someone better, where are they? They would be well known by now.
I’ll admit, this part I have really no say in as I’m unsure of what happened here myself.

However, yes there are a lineup of good announcements to come, and yes maybe you are right turnout could be quicker, but not in these market conditions, it’s going to take longer. IMO.

From a technical standpoint, the share price needs to cross 10c and convincingly to be sound again.
Fundamentally, it’s time to meet with the FDA crew, and get the sleep apnea moving along at full pace!

The story is not over yet, in this health technology space, bad announcements are punishable by death, as we saw today, but much more versatile to regain strength.